Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Tokyo Tanabe claims antifungal agents

March 3, 1997

Amphotec now approved in 20 countries

Feb. 28, 1997

Pfizer's new antifungal agents

Feb. 27, 1997

Favorable results reported for Mentax

Feb. 26, 1997

Recurrent herpes treatment development advances

Feb. 26, 1997

Zanamivir enters pivotal trials

Feb. 26, 1997

Antiherpesvirus agents reported by Bio-Mega/Boehringer Ingelheim

Feb. 25, 1997

Antiviral nucleoside analogues available for licensing

Feb. 24, 1997

Alpha-Beta/MycoTox antifungal collaboration

Feb. 21, 1997

New agreement reached for Searle's Maxaquin

Feb. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...